A novel drug management system in the Febuxostat versus Allopurinol Streamlined Trial: A description of a pharmacy system designed to supply medications directly to patients within a prospective multicenter randomised clinical trial

Amy Rogers, Robert W V Flynn, Patrick McDonnell, Isla S. Mackenzie, Thomas M. Macdonald

Research output: Contribution to journalArticle

1 Citation (Scopus)
179 Downloads (Pure)

Abstract

Background: Trials of investigational medicinal products are required to adhere to strict guidelines with regard to the handling and supply of medication. Information technology offers opportunities to approach clinical trial methodology in new ways. This report summarises a novel pharmacy system designed to supply trial medications directly to patients by post in the Febuxostat versus Allopurinol Streamlined Trial.

Method: A bespoke web-based software package was designed to facilitate the direct supply of trial medications to Febuxostat versus Allopurinol Streamlined Trial participants from a pharmacy based in the Medicines Monitoring Unit, University of Dundee.

Results: To date, 65,467 packs of medication have been dispensed using the system to 3978 patients. Up to 238 packs per day have been dispensed.

Conclusion: The Medicines Monitoring Unit Febuxostat versus Allopurinol Streamlined Trial drug management system is an effective method of administering the complex drug supply requirements of a large-scale clinical trial with advantages over existing arrangements. A low rate of loss to follow-up in the Febuxostat versus Allopurinol Streamlined Trial may be attributable to the drug management system.

Original languageEnglish
Pages (from-to)665-670
Number of pages6
JournalClinical Trials
Volume13
Issue number6
Early online date2 Jul 2016
DOIs
Publication statusPublished - 1 Dec 2016

    Fingerprint

Keywords

  • Clincal trials
  • drugs
  • investigational
  • Internet
  • pharmacy
  • pharmaceutical services

Cite this